Genomic, molecular biology and malaria: New medical perspectives?;Génomique, biologie moléculaire et paludisme: Quelles avancées médicales?

Bulletin de la Societe de Pathologie Exotique

Volumn 97, Issue 3, 2004, Pages 155-160

  Ambroise Thomas, P ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

Anopheles gambiae; Antimalarial drug; Apicoplast; DNA vaccine; Genomic; Malaria; Molecular biology; Pathophysiology; Plasmodium falciparum; Vaccine

Indexed keywords

ANTIMALARIAL AGENT; DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MALARIA VACCINE; PROTEINASE; VIRUS PROTEIN;

ANOPHELES GAMBIAE; ANTIGENICITY; APICOPLAST; CELLULAR IMMUNITY; EVOLUTION; GAMETOCYTE; GENE CONTROL; GENETIC MANIPULATION; GENOMICS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MALARIA; MALARIA CONTROL; MEROZOITE; PARASITE VECTOR; PATHOPHYSIOLOGY; PHYLOGENY; PLASMODIUM FALCIPARUM; REVIEW; SPOROZOITE;

EID: 4444296408     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. ABEL L - Apport de l'épidémiologie génétique pour l'étude de la susceptibilité/résistance au paludisme dans les populations humaines. Bull Soc Pathol Exot, 1999, 92, 256-260.
2. AMBROISE-THOMAS P - Paludisme, génétique et biologie moléculaire: mythes, espoirs, réalités. Ann Pharm Fr, 2001, 59, 95-104.
3. BHARDWA JD, HORA B, SINGH N et al. - Immunogenicity and protective efficacy of three DNA vaccines encoding preerythrocytic and erythrocytic stage antigens of Plasmodium falciparum in rhesus monkey. FEMS Immunol Med Microbiol, 2002, 34, 33-43.
4. BOETE C & KOELLA JC - Evolutionary ideas about genetically manipulated mosquitoes and malaria control. Trends Parasitol, 2003, 19, 32-38.
5. BURT RA - Genetics and host response to malaria. Int J Parasitol, 1999, 29, 973-979.
6. BUTLER D - What difference does a genome make? Nature, 2002, 419, 426-428.
7. CATTERUCIA F, GODFRAY HC & CRISANTI A - Impact of genetic manipulation on the fitness of Anopheles stephensi mosquitoes. Science, 2003, 21, 1225-1227.
8. CLEGG JB & WEATHERALL DJ - Thalassemia and malaria: new insights into an old problem. Proc Assoc Am Physicians, 1999, 111, 278-282.
9. COLUZZI M & COSTANTINI C - An alternative focus in strategic research on disease vectors: the potential of genetically modified non biting mosquitoes. Parasitologia, 2002, 44, 131-135.
10. DUFFY MF, REEDER JC & BROWN GV - Regulation of antigenic variation in Plasmodium falciparum: censoring freedom of expression? Trends Parasitol, 2003, 19, 121-124.
11. EPSTEIN JE, GORAK EJ, CHAROENVIT Y, WANG R, FREYDBERG N et al. - Safety, tolerability and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes. Hum Gen Ther, 2002, 13, 1551-1560.
12. FLORENS L, WASHBURN MP, RAINE JD, ANTHONY RM, GRAINGER M et al. - A proteomic view of the Plasmodium falciparum life cycle. Nature, 2002, 419, 520-526.
13. FORTIN A, STEVENSON MM & GROS P - Susceptibility to malaria as a complex trait: big pressure from a tiny creature. Hum Mol Genet, 2002, 11, 2469-2478.
14. FOTH BJ, RALPH SA, TONKIN CJ, STRUCK NS, FRAUNHOLZ M et al. - Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. Science, 2003, 299, 705-708.
15. FOX AN, PITTS RJ & ZWIEBEL LJ - A cluster of candidate odorant receptors from the malaria vector mosquito, Anopheles gambiae. Chem senses, 2002, 27, 453-459.
16. GRUNER AC, BRAHIMI K, ELING W, KONINGS R, MEIS J et al. - The Plasmodium falciparum knob-associated PfEMP13 antigen is also expressed at the pre-erythrocytic stages and induces antibodies which inhibit sporozoite invasion. Mol Biochem Parasitol. 2001, 112, 253-261.
17. GRUNER AC, BRAHIMI K, LETOURNEUR F, RENIA L, ELING W et al. - Expression of the erythrocyte-binding antigen 175 in sporozoïtes and in liver stages of Plasmodium falciparum. J Infect Dis, 2001, 184, 892-897.
18. GRUNER AC, SNOUNOU G, BRAHIMI K, LETOURNEUR F, RENIA L et al. - Pre-erythrocytic antigens of Plasmodium falciparum: from rags to riches? Trends Parasitol, 2003, 19, 74-78.
19. HEMINGWAY J, FIELD L & VONTAS J - An overview of insecticide resistance. Science, 2002, 298, 96-97.
20. HILL AV - The immunogenetics of resistance to malaria. Proc Assoc Am Physicians, 1999, 111, 272-277.
21. HILL AV - The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet, 2001, 2, 373-400.
22. HIRAYAMA K - Genetic factors associated with development of cerebral malaria and fibrotic schistosomiasis. Korean J Parasitol, 2002, 40, 165-172.
23. ITO J, GHOSH A, MOREIRA LA, WIMMER EA & JACOBS-LORENA M - Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite. Nature, 2002, 417, 4532-4555.
24. JOACHIMIAK MP, CHANG C & ROSENTHAL PJ & COHEN FE - The impact of whole genome sequence data on drug discovery - a malaria case study. Mol Med, 2001, 1, 698-710.
25. JOMAA H, WIESNER J, SANDERBRAND S, ALTINCICEK B, WEIDEMEYER C et al. - Inhibitors of the non melavonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science, 1999, 285, 1502-1503.
26. KOCH O, AWOMOYI A, USEN S, JALLOW M, RICHARDSON A et al. - IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J Infect Dis, 2002, 185, 1684-1687.
27. KUMAR S, EPSTEIN JE, RICHIE TL, NKRUMAH FK, SOISSON L et al. - A multilateral effort to develop DNA vaccines against falciparum malaria. Trends Parasitol, 2002, 18, 129-135.
28. LAMBERT G - La légende des gènes. Anatomie d'un mythe moderne. Dunod, Univers Sciences Ed. Paris, 2003, 292p.
29. LAND KM - The mosquito genome: perspectives and possibilities. Trends Parasitol, 2003, 19, 103-105.
30. LEKANA DOUKI JB, STERKERS Y, LEPOLARD C, TRAORE B, COSTA FT et al. - Adhesion of normal and P. falciparum ring-infected erythrocytes to endothelial cells and the placenta involves the rhoptry-derived Ring Surface Protein-2. Blood, 2003, 100, 1478-1483.
31. LELL B, RUANGWEERAYUT R, WIESNER J, MISSINOU MA, SCHINDLER A et al. - Fosmidomycin, a novel chemotherapeutic agent for malaria. Antimicrob Agents Chemother, 2003, 47, 735-738.
32. Mc GUYIRE W, KNIGHT JC, HILL AV, ALLSOPP CE, GREENWOOD BM et al. - Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis, 1999, 179, 287-290.
33. MAZIER D & IDRISSA-BOUBOU M - Immunogénétique et paludisme cérébral. Bull Soc Pathol Exot, 1999, 92, 249-255.
34. MAZIER D, NITCHEU J & IDRISSA-BOUBOU M - Cerebral malaria and immunogenetics. Parasite Immunol, 2000, 22, 613-623.
35. MILLER LH, BARUCH DJ, MARSH K & DOUMBO OK - The pathogenesis basis of malaria. Nature, 2002, 415, 673-679.
36. MOREIRA LA, GHOSH AK, ABRAHAM EG & JACOBS-LORENA M - Genetic transformation of mosquitoes: a quest for malaria control. Int J Parasitol, 2002, 32, 1599-1605.
37. NIARE O, MARKIANOS K, VOLZ J, ODUOL F, TOURE A et al. - Genetic loci affecting resistance to human malaria parasites in a west African mosquito vector population. Science, 2002, 298, 213-216
38. OMI K, OHASHI J, PATARAPOTIKUL J, HANANANTACHAI H, NAKA I et al. - CD36 polymorphism is associated with protection from cerebral malaria. Am J Hum Genet, 2003, 72, 364-374.
39. PATEL SS, MEHLOTRA RK, KASTENS W, MGONE CS, KAZURA JW. et al. - The association of the glycophorin C exon deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. Blood, 2001, 98, 3489-3491.
40. PAUGAM A, BULTEAU AL, DUPOUY-CAMET J CREUZET C & FRIGUET B - Characterization and role of protozoan parasite proteasomes. Trends Parasitol, 2003, 19, 55-59.
41. PETERS J, FOWLER E, GATTON M, CHEN N, SAUL A et al. - High diversity and rapid change over of expressed var genes during the acute phase of Plasmodium falciparum infections in human volunteers. Proc Natl Acad Sci USA, 2002, 99, 10689-10694.
42. RANSON H, CLAUDIANOS C, ORTELLI F, ABGRALL C, HEMINGWAY J et al. - Evolution of supergene families associated with insecticide resistance. Science, 2002, 298, 179-181.
43. RANSON H, NIKOU D, HUTCHINSON M, WANG X, ROTH CW et al. - Molecular analysis of multiple cytochrome P450 genes from the malaria vector Anopheles gambiae. Insect Mol Biol, 2002, 11, 409-418.
44. RATHOD PK, GANESAN K, HAYWARD RE, BOZDECH Z & DERISI JL - DNA microarrays for malaria. Trends Parasitol, 2002, 18, 39-45.
45. RITCHIE TL & SAUL A - Progress and challenges for malaria vaccines. Nature, 2002, 415, 694-701.
46. ROBINSON BA, WELCH TL & SMITH JD - Widespread functionnal specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD 36 analysed across a parasite genome. Mol Microbiol, 2003, 47, 1265-1278.
47. SUROLIA N & SUROLIA A - Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat Med, 2001, 7, 167-173.
48. THOMASSOVA D, TON LQ, COPLEY RR, ZDOBNOV EM, WANG X et al. - Comparative genomic analysis in the region of a major Plasmodium-refractoriness locus of Anopheles gambiae. Proc Natl Acad Sci USA, 2002, 99, 8179-8184.
49. TROYE-BLOMBERG M - Genetic regulation of malaria infection in humans. Chem Immunol, 2002, 80, 243-252.
50. WEATHERALL DJ & CLEGG JB - Genetic variability in response to infections: malaria and after. Genes Immun, 2002, 3, 331-337.
51. WIESNER J, HENSCHKER D, HUTCHINSON DB, BECK E & JOMAA H - In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin. Antimicrob Agents Chemother, 2002, 46, 2889-2894.
52. WIMMER EA - Innovations: applications of insect transgenesis. Nat Rev Genet, 2003, 4, 225-232.
53. WU Y, WANG X, LIU X & WANG Y - Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite. Genome Res, 2003, 13, 601-616.
54. WYRTH DF - The parasite genome: biological revelations. Nature, 2002, 419, 495-496.
55. ZUEGGE J, RALPH S, SCHMUKER M, McFADDEN G.I. & SCHNEIDER G - Deciphering apicoplast targeting signals feature extraction from nuclear-encoded precursors of Plasmodium falciparum apicoplast proteins. Gene, 2001, 280, 19-26.